94 related articles for article (PubMed ID: 2862111)
1. Simple approach to assess potentiated drug combinations in clinical trials: studies with pirenzepine plus H2-receptor antagonists.
Pöch G; Londong W
Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):283-7. PubMed ID: 2862111
[TBL] [Abstract][Full Text] [Related]
2. Modern approach to the evaluation of combined effects of single-dose trials and clinical time-course studies, exemplified by combinations of pirenzepine and H2-receptor antagonists.
Pöch G; Londong W
Int J Clin Pharmacol Ther Toxicol; 1993 Oct; 31(10):483-8. PubMed ID: 8262686
[TBL] [Abstract][Full Text] [Related]
3. Interactions of cimetidine and pirenzepine on peptone-stimulated gastric acid secretion in man.
Londong W; Londong V; Prechtl R; Weber T; von Werder K
Scand J Gastroenterol Suppl; 1980; 66():103-14. PubMed ID: 6941373
[TBL] [Abstract][Full Text] [Related]
4. Complete inhibition of food-stimulated gastric acid secretion by combined application of pirenzepine and ranitidine.
Londong W; Londong V; Ruthe C; Weizert P
Gut; 1981 Jul; 22(7):542-8. PubMed ID: 6114900
[TBL] [Abstract][Full Text] [Related]
5. Potentiation of the gastric antisecretory activity of histamine H2-receptor antagonists by clebopride.
Fernández AG; Massingham R; Roberts DJ
Methods Find Exp Clin Pharmacol; 1988 May; 10(5):285-93. PubMed ID: 2899659
[TBL] [Abstract][Full Text] [Related]
6. Comparative effects of pirenzepine and cimetidine, alone and in combination, on 24-hour gastric acidity in duodenal ulcer disease.
Mahachai V; Reilly P; Thomson AB
Clin Ther; 1984; 7(1):98-111. PubMed ID: 6394132
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of food stimulated acid secretion by association of pirenzepine and ranitidine in duodenal ulcer patients.
Lazzaroni M; Sangaletti O; Parente F; Imbimbo BP; Bianchi Porro G
Int J Clin Pharmacol Ther Toxicol; 1986 Dec; 24(12):685-8. PubMed ID: 3818148
[TBL] [Abstract][Full Text] [Related]
8. Do anticholinergics interact with histamine H2 receptor antagonists on night intragastric acidity in active duodenal ulcer patients?
Fiorucci S; Clausi GG; Farinelli M; Santucci L; Farroni F; Pelli MA; Morelli A
Am J Gastroenterol; 1988 Dec; 83(12):1371-5. PubMed ID: 2904218
[TBL] [Abstract][Full Text] [Related]
9. The role of antagonists to acid secretion.
Dinoso VP
Compr Ther; 1982 Dec; 8(12):22-5. PubMed ID: 6130868
[No Abstract] [Full Text] [Related]
10. Comparison between ranitidine, cimetidine, pirenzepine and placebo in the short term treatment of duodenal ulcer.
Giacosa A; Cheli R; Molinari F; Parodi MC
Scand J Gastroenterol Suppl; 1982; 72():215-9. PubMed ID: 6291138
[TBL] [Abstract][Full Text] [Related]
11. [Is strong inhibition of gastric acid in the treatment of peptic ulcer sensible?].
de Bruijne JW; Lamers CB
Ned Tijdschr Geneeskd; 1989 Apr; 133(13):657-62. PubMed ID: 2566125
[No Abstract] [Full Text] [Related]
12. The inhibition of vagal stimulated acid secretion by pirenzepine and cimetidine.
Scholten T; Fritsch WP; Müller JE; Hengels KJ
Scand J Gastroenterol Suppl; 1982; 72():169-71. PubMed ID: 6957986
[TBL] [Abstract][Full Text] [Related]
13. Addition of misoprostol to ranitidine in non-responders to H2-blockers and pirenzepine.
Walker S; Sarem-Aslani A; Treiber G; Klotz U; Bode JC
Neth J Med; 1991 Feb; 38(1-2):18-23. PubMed ID: 1674363
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states.
Jensen RT; Collen MJ; McArthur KE; Howard JM; Maton PN; Cherner JA; Gardner JD
Am J Med; 1984 Nov; 77(5B):90-105. PubMed ID: 6150641
[TBL] [Abstract][Full Text] [Related]
15. [Incidence of gastro-duodenal stress lesions in trauma patients requiring intensive care, treated with secretory inhibitors. A double blind study].
Barandun J; Leutenegger A; Frutiger A; Rüedi T; Kobler E
Schweiz Rundsch Med Prax; 1984 Sep; 73(38):1145-6. PubMed ID: 6149610
[No Abstract] [Full Text] [Related]
16. [Current aspects of the therapy of gastroduodenal peptic ulcer].
Castro Lde P
Rev Hosp Clin Fac Med Sao Paulo; 1983; 38(2):90-102. PubMed ID: 6139870
[No Abstract] [Full Text] [Related]
17. The effect of a 100 mg pirenzepine--treatment on acid secretion and serum gastrin.
Fritsch WP; Scholten T; Müller J; Hengels KJ; Hanrath KD
Scand J Gastroenterol Suppl; 1982; 72():173-7. PubMed ID: 6957987
[TBL] [Abstract][Full Text] [Related]
18. [Effect of inhibitors of acid secretion in patients with duodenal ulcer. Comparative study of cimetidine, ranitidine and pirenzepine].
Espinoza M; Csendes A; Medina LA; Fuster F; Braghetto I; Encina J
Rev Med Chil; 1984 Nov; 112(11):1085-9. PubMed ID: 6152639
[No Abstract] [Full Text] [Related]
19. Comparison of famotidine with cimetidine and ranitidine.
Berardi RR; Tankanow RM; Nostrant TT
Clin Pharm; 1988 Apr; 7(4):271-84. PubMed ID: 2896559
[TBL] [Abstract][Full Text] [Related]
20. [Prevention of acute stress hemorrhages of the upper gastrointestinal tract with pirenzepine and antacids. A controlled comparison between pirenzepine and cimetidine].
Tryba M; Zevounou F; Grabhoefer P; Seifert V; Török M
Anasth Intensivther Notfallmed; 1984 Oct; 19(5):240-4. PubMed ID: 6393814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
